Allied Market Research
Loading...
0

Asia-Pacific Hospital-Acquired Infection Diagnostics Market Expected to Reach $780.882 Million by 2027—Allied Market Research

 

Report Code : A08861

quote The growth of the Asia-Pacific hospital-acquired infection diagnostics market is attributed to increase in number of patients suffering from chronic infection, respiratory disease, bloodstream infections, and rise in aging population are expected to drive the growth of the market. However, the rise in awareness in healthcare workers regarding hospital-acquired infection is one of the factors that contributes toward the growth of the market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Asia-Pacific Hospital-Acquired Infection Diagnostics Market by Product, Test type, Infection type, End user, and Country: Opportunity Analysis and Industry Forecast, 2020–2027," The Asia-Pacific hospital-acquired infection diagnostics market accounted for $418.937 million in 2019, and is expected to reach $780.882 million by 2027, registering a CAGR of 7.5% from 2020 to 2027.

Healthcare facilities in Asia-Pacific pose a unique infection risk to patients. Infections contracted during hospital stays lead to unnecessary suffering and death for millions of patients every year. Such infections are called hospital-acquired infections (HAIs), and can be defined simply as an infection contracted in a hospital environment. Furthermore, HAI are mainly caused by bacteria, viruses and fungi. Most of these diseases can be contracted anywhere, but they present greater challenges in the healthcare setting, and are costly to deal with, both financially and in terms of physical and staff resources. Hence, fuels growth of the Asia-Pacific hospital-acquired infection diagnostics market.

Most of the markets are dropping down, owing to the outbreak, including the Asia-Pacific hospital-acquired infection diagnostics market. The Asia-Pacific hospital-acquired infection diagnostics market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, most of the leading companies across the globe have slow down the manufacturing of other products. Furthermore, the individual contributions companies are collaborating to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19 patients.

As per the expresshealthcare.in, the findings specified that 7.92 central line-associated bloodstream infections occurred per 1,000 central line-days, 10.6 catheter-associated urinary tract infections per 1,000 urinary catheter-days and a ventilator-associated pneumonia rate of 10.4 per 1,000 mechanical ventilator-days in 2019. Furthermore, rise in the geriatric population, coupled with an increase in life-threatening diseases such as obesity, cancer, diabetes, respiratory and heart diseases, and is augmenting market demand. The implementation of strict government policies to control the level of infections and increasing focus on sterilization of food will foster Asia-Pacific hospital-acquired infection diagnostics market growth. In recent years, infectious disease diagnosis has gained relevance like never before, due to the development of new diseases and evolving pathogens. Effective diagnosis plays a pivotal role in preventing community transmission and avoiding the outbreak of diseases among the population. Moreover, rise in demand for the prevention of hospital-acquired infection will create a need for the market product.

On the basis of product type, the reagent and consumables segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the forecast period. Growth of the segment is attributed to rise in the number of patients suffering from various infectious diseases and high prevalence of hospital acquired infections in low and middle income countries.

On the basis of test type, the molecular diagnostics segment is estimated to garner largest share during the forecast period. This is due to advantages of molecular diagnostics for infectious diseases, such as detection of lower amounts of infectious agents, provide an effective yet simple tool to establish efficacy of therapy, and modify treatment when appropriate. Furthermore, the increasing incidence of infectious diseases and the mammoth rise in reported cancer cases are fueling market growth.

On the basis of application, the surgical site infections segment is estimated to garner largest share during the forecast period. This attributed to the low awareness regarding HAIs among healthcare workers and rise in number of surgeries.

On the basis of end user, the hospital segment is estimated to garner largest share in 2019. It is expected to maintain its dominant position throughout the analysis period. Furthermore, rise in number of patients diagnosed with infectious diseases and the high probability of infections in hospital premises through blood-borne or respiratory pathogen transmission are also anticipated to boost the market growth. 

The growth in the number of surgeries in hospitals and increase in no. of hospital stay is also augmenting the demand of the Asia-Pacific hospital-acquired infection diagnostics market. 

India is the largest country segment of the Asia-Pacific hospital-acquired infection diagnostics market. However, the Sri Lanka and Myanmar is expected to witness significant growth in the coming years, primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism, and rising aging population with the resultant increase in the number of chronic disease cases, will further boost the Asia-Pacific hospital-acquired infection diagnostics market.

Key Findings Of The Study 

  • The study provides an in-depth analysis, current trends, and future estimations of the Asia-Pacific hospital-acquired infection diagnostics market to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • By product type, the reagent and consumables segment is anticipated to grow at a CAGR of 8.0% from 2020 to 2027.
  • Extensive analysis of key segments of the industry help to understand the types of products and technologies used across various countries.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Asia-Pacific Hospital-Acquired Infection Diagnostics Market By Product (Instrument and Reagents & Consumables) By Infection Type (Procedural Sedation, Pain Management, Emergency Medicine, Critical Care, General Floor, and Others), By Test Type (Molecular Diagnostics, Urinalysis, And Immunoassay) and End Use (Hospitals, Clinics and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027 quote

View Report
 
 
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 3,513 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Jan 2021

Surgical Equipment Market

Download Sample
rep-img

Published Date Nov 2020

Medical Implant Market

Download Sample
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Asia-Pacific Hospital-Acquired Infection Diagnostics Market"
Purchase Enquiry